Dorsey Brian 4
4 · ARS Pharmaceuticals, Inc. · Filed Aug 21, 2024
Insider Transaction Report
Form 4
Dorsey Brian
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2024-08-20$0.64/sh+50,000$32,000→ 56,024 total - Sale
Common Stock
2024-08-20$15.00/sh−50,000$750,000→ 6,024 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-08-20−50,000→ 61,828 totalExercise: $0.64Exp: 2028-11-28→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 31, 2023.
- [F2]Immediately exercisable.